Cabaletta Bio, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$172.2 | -$125.1 | -$74.7 | -$54.1 | -$46.3 |
| Net income | -$167.9 | -$115.9 | -$67.7 | -$53.0 | -$46.3 |
| Cash Flow Statement | |||||
| Free cash flow | -$132.3 | -$90.4 | -$54.2 | -$48.8 | -$35.3 |
Shares outstanding 163.1M · Free float 99.2%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.